Neslihan Arife Kaya

机构：Agency for Science, Technology and Research, Genome Institute of Singapore · ORCID：0000-0002-0213-3072

发表论文 25 篇 · 总被引 654 次 · h-index 12

代表论文

• Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma (2021 · Nature Communications · 被引 140)
• Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial (2021 · ˜The œLancet. Gastroenterology & hepatology · 被引 138)
• Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma (2022 · Journal of Hepatology · 被引 123)
• Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study (2021 · National Science Review · 被引 85)
• A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and ‘bad apple’ effect on clinical trajectory (2024 · Journal of Hepatology · 被引 21)
• Tumor phylogeography reveals block-shaped spatial heterogeneity and the mode of evolution in Hepatocellular Carcinoma (2024 · Nature Communications · 被引 21)